Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1950;2:369-372

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HOGBEN, C. A. M.
Right arrow Articles by ALLEN, E. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOGBEN, C. A. M.
Right arrow Articles by ALLEN, E. V.

(Circulation. 1950;2:369.)
© 1950 American Heart Association, Inc.


The Relationship between Prothrombin Time and Bleeding in the Clinical Use of Dicumarol after Operation

C. ADRIAN M. HOGBEN M.D.1 EDGAR V. ALLEN M.D.1

1 From the Division of Medicine, Mayo Clinic, Rochester, Minn.

Experienced clinicians have known for some time that bleeding owing to the use of dicumarol is not entirely a measure of the degree of prothrombin deficiency. This presentation emphasizes that bleeding may occur when prothrombin deficiency is not great and that bleeding may fail to occur when prothrombin deficiency is marked. Nonetheless great prothrombin deficiency causes bleeding more frequently than lesser degrees of prothrombin deficiency. Time is an important factor, for patients are much more apt to bleed when prothrombin deficiency has endured for several days than when it has been present only a day or so.